- Grants Awarded to Scientists For Carcinoid Tumor And Pancreatic Neuroendocrine Tumor Research
27 Mar 2011
- Pancreatic Cancer Action Network AACR Pathway To Leadership Grants Awarded To Early-Career Investigators
26 Mar 2011
- Pancreatic Cancer Action Network And AACR Award Research Grants Totaling Nearly $3 Million
25 Mar 2011
- Adamis Reports APC-300 Kills Human Pancreatic Cancer Cells
25 Mar 2011
- Novel Immune Therapy For Pancreatic Cancer: Drug Stimulates Immune System To Attack ‘Scaffolding’ Around Tumors
25 Mar 2011
- Protecting Pancreatic Cells From Alcohol’s Toxic Effects
23 Mar 2011
- Suppressing The Formation Of Mucus May Allow Drugs Through To The Cancer Cells Beneath
18 Mar 2011
- Malaria Drug Slows Pancreatic Cancer Growth In Mouse Models
16 Mar 2011
- Killer Pancreatic Cancer Stems From Drinking Without Smoke
16 Mar 2011
- Heavy Drinking Associated With Increased Risk Of Death From Pancreatic Cancer
14 Mar 2011
- Jasco Pharmaceuticals Initiates A Collaborative Research Program In Pancreatic Cancer With North Carolina Central University
14 Mar 2011
- ‘GlobalCure,’ Seeking Promising New Clinical Therapies For Pancreatic Cancer
14 Mar 2011
- Potential New Drug To Treat Leukemia, Non-Small-Cell Lung Cancer, Prostate And Pancreatic Cancers
10 Mar 2011
- Researchers Develop Synthetic Compound That May Lead To Drugs To Fight Pancreatic, Lung Cancer
10 Mar 2011
- Pancreatic Cancer Action Network – AACR Pathway To Leadership Grants Awarded To Early-Career Investigators
9 Mar 2011
- Increasing The Effectiveness Of Treatment For Pancreatic Cancer
7 Mar 2011
- BioSante’s Pancreas Cancer Vaccine Shows Survival Increase In Newly Published Study
6 Mar 2011
- Turmeric Might Be “The Right Spice” To Fight Colon Cancer And Inflamation
4 Mar 2011
- Omeros Unlocks Orphan GPCRs Linked To Pancreatic Cancer And Cognitive Disorders
3 Mar 2011
- Discovery Of Protein That Fuels Inflammation In Pancreatic And Breast Tumors
22 Feb 2011
- Oncolytics Biotech(R) Inc. Announces Start Of Enrollment In Randomized Phase II Pancreatic Cancer Study
18 Feb 2011
- Whole Genome Sequencing Used To Help Inform Deadly Pancreatic Tumor Therapy
17 Feb 2011
- Oncolytics Biotech® Inc. Meets Primary Endpoint For First Part Of U.S. Phase 2 Pancreatic Cancer Clinical Trial
15 Feb 2011
- Novartis’ Afinitor May Help Steve Job’s Rare Pancreatic Cancer
10 Feb 2011
- Everolimus Improves Progression-Free Survival For Patients With Rare Pancreatic Cancer
10 Feb 2011
- Clavis Pharma’s CP-4126 Enters New Phase II Clinical Trial In Pancreatic Cancer Patients Refractory To 1st Line Gemcitabine Therapy
3 Feb 2011
- Ohio State University To Lead New Pancreatic Cancer Trial
26 Jan 2011
- PharmaEngine Reports That PEP02 Met The Primary Endpoints In Phase II Studies In Gastric Cancer And Pancreatic Cancer
26 Jan 2011
- FibroGen Reports Interim Results Of A Phase 1 / 2 Trial Of FG-3019 In Locally Advanced Or Metastatic Pancreatic Cancer
25 Jan 2011
- Online Physician Education Program Outlines Treatment Strategies For Pancreatic Cancer
23 Jan 2011
- NewLink Genetics To Present Phase 2 Data Of Its HyperAcute® Pancreas Immunotherapy At ASCO 2011 Gastrointestinal Cancers Symposium
22 Jan 2011
- Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing The Utility Of ChemoFx® In Cancer Treatment Options
21 Jan 2011
- Caring For Carcinoid Foundation-Funded Researchers Illuminate Genetic Code For A Form Of Pancreatic Cancer
21 Jan 2011
- Johns Hopkins Scientists Crack Genetic Code For Form Of Pancreatic Cancer
21 Jan 2011
- Scientists Crack Rare Pancreatic Cancer Genetic Code And Highlight Role Of Epigenetics
21 Jan 2011
- Oncolytics Biotech(R) Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study
21 Jan 2011
- Roundworm Unlocks Pancreatic Cancer Pathway
20 Jan 2011
- Pancreatic Cancer; Henry Ford Hospital Launches Study To Develop Screening Test
14 Jan 2011
- University Of Oklahoma Scientists Discover Way To Stop Pancreatic Cancer In Early Stages
13 Jan 2011
Donate
Thanks for visiting. The efforts of this organization are solely supported by donations and grants. We are a non-profit 501c3, so your donation is tax-deductible.
Mission Statement
The purpose of this site is to serve as a focal and gathering point on the Internet for some of the latest news and information in regard to responsible medical care in the treatment of cancer.